Comparative study on the esterification of gymnodimine in different shellfish exposed to the dissolved toxin in seawater.

Some lipophilic phycotoxins dissolved in seawater can be accumulated by bivalves via the filtering process. To explore the relationship between the bioaccumulation of gymnodimine-A (GYM-A) and free fatty acids (FFAs) of shellfish, three species of bivalves (venus clam Meretrix meretrix, mussel Mytilus galloprovincialis, and ark shell Anadara kagoshimensis) were exposed to dissolved GYM-A for 7 days in the same seawater system. Results indicated that GYM-A can be accumulated by these bivalves from the dissolved phase and esterified with FFAs reaching over 90% in most tissues of bivalves. Gymnodimine-A and its esters mainly distributed in the gills of shellfish, and the highest concentration of toxins occurred in mussel, followed by ark shell and venus clam. Similar percent of different fatty acid esters occurred in the experimental shellfish, in which the C16:0, C17:0, C18:0, C18:1, C20:1, C20:2, C22:2, and C22:6-GYM-A esters were the main metabolites of GYM-A. The binding capacity of fatty acids and GYM-A varied in different FFAs, which can explain why the C20:1-GYM-A ester dominated the ester profile while C16:0 was the most abundant fatty acid in all samples. Comparing with the FFA profile of shellfish in the control groups, overexpression of some FFAs occurred in the tissues of shellfish exposed to GYM-A in the experimental groups, which suggested that biosynthesis of FFAs was affected by the accumulation and metabolism of GYM-A in bivalves. Multiple fatty acids including some valuably nutritional FFAs such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were consumed in the esterification metabolism of GYM-A, which hinted that the lipid metabolism and nutritional quality of shellfish affected by the contamination of GYMs should be explored and assessed in future works.

Prevalence and distribution of domoic acid and cyclic imines in bivalve mollusks from Beibu Gulf, China.

Beibu Gulf is an important shellfish aquaculture area in the northwest of the South China Sea, China. In this study, the toxin profile and spatial-temporal distribution of domoic acid (DA) and 10 lipophilic phycotoxins were systematically analyzed in the bivalve mollusks collected in Beibu Gulf from October 2018 to October 2020. Neurotoxin DA was first detected in the mollusks from the investigative regions with a prevalence of 17.7%, peaking at 401 µg kg-1. Cyclic imines (CIs) including gymnodimine-A (GYM-A, 46.6%) and 13-desmethyl-spirolide-C (SPX1, 15.8%) predominated the lipophilic phycotoxins in shellfish, peaking at 10.1 µg kg-1 and 19.6 µg kg-1, respectively. Gymnodimine-A partially accompanied by SPX1 was detected in all batches of shellfish samples, suggesting that Alexandrium ostenfeldii and Karenia selliformis were possible sources of CIs-group toxins in Beibu Gulf. During the investigative period, relatively higher levels of DA occurred in shellfishes from March to August, while slightly higher contents of CIs in mollusks appeared in October and December. Spatial distribution of the targeted phycotoxins demonstrated that shellfishes tended to accumulate relatively higher contents of toxins in Lianzhou, Qinzhou and Tieshan bays.

Electrodeposition of Biocomposite Film Onto ZnO Nanoparticles Modified Electrode for Closed-Loop Insulin Delivery.

In this study, glucose responsive bioinorganic composite (BIM) was prepared through chitosan microparticles coupling concanavalin A, enzymes and dextran-insulin via specific affinity. The drug-delivery device was fabricated by electrodeposition of BIM onto the nanostructured ZnO on indium tin oxide (ITO) substrate. The release profiles of device revealed that the insulin release was in response to the glucose concentration in vitro experiment. The released insulin still remained the activity after running the whole process and the device showed the capability for glucose sensing continuously. All these results suggest that the device may be a promising system for self-regulated insulin delivery and glucose monitoring.